HopeStage
Back to all studies
CompletedNCT00802100

Comparing antipsychotic treatment plans for adults with schizophrenia

About this titleRead the official source — NCT00802100
Medication studyAges 18–40United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 40 years.

What did participation involve?

The protocol includes: Completing questionnaires.

Listed locations
Colton and 12 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateDecember 2008
Recruitment status
Completed
Enrollment listed in the registry
21
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 40 Years
Official registry ID
NCT00802100
Official title
Show the full official title

Comparison of Optimal Antipsychotic Treatments for Schizophrenia Pilot Study

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Colton · Palo Alto · New Haven

10 more locations
  • Miami
  • Augusta
  • Glen Burnie
  • Worcester
  • Detroit
  • Minneapolis
  • New York
  • Butner
  • Dallas
  • Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did participation involve?

The protocol called for participants to complete questionnaires.

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine, Perphenazine, Aripiprazole, Metformin, Simvastatin and Benztropine.

Who was this study for?

Listed age limits: 18 years to 40 years.

Want to explore more studies?

Explore studies